KEEP BUT DO NOT DISPLAY

Developed by Stanford University School of Medicine researchers, the skin patch has an array of microneedles to painlessly poke holes in the top layer of skin, gradually releasing medication. The main ingredient of the medication, deferoxamine, helps to promote the growth of new networks of small blood vessels needed to …

Patients with diabetic peripheral neuropathy were slower and clumsier than their healthier counterparts when going up and down stairs due in part to weak muscles, poor coordination and sensory damage, according to a study. However, researchers said resistance training may help patients build up strength and reduce the risk of …

The researchers found that dietary iron plays an important role in the circadian clock of the liver. “Iron is like the dial that sets the timing of the body clock,” said lead author Judith Simcox from the University of Utah in the US. The liver’s circadian clock is set by …

Type 2 diabetes patients exhibited a weak ability to regulate blood pressure, cholesterol and heart rate when they experienced stress, a new study showed. Researchers also noted increased depressive and hostile symptoms in these patients. The researchers looked at the biological systems of 140 patients with type 2 diabetes and …

Cleveland Clinic researchers found that high-intensity statin treatment was associated with coronary atheroma regression in patients with or without diabetes, suggesting the therapy may halt the progression of diabetic coronary atherosclerosis. Coronary atheroma volume was measured using serial intravascular ultrasound in patients treated with rosuvastatin 40 mg or atorvastatin 80 …

Trulicity Once-Weekly GLP-1 Shipping Now  Eli Lilly and Company announced that Trulicity, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) with once-weekly dosing in the Trulicity pen, was approved by the FDA on September 18, 2014, and is shipping to distributors now.

A new follow up study looked at a previous clinical trial in patients with type 2 diabetes. The initial study was conducted with 61 subjects with diabetes. The patients were randomized either to a low-carbohydrate diet or a low-fat diet, both with a caloric content of 1600 kcal for women …

Exposure to cold temperatures can convert white fat tissue from the thighs and belly to beige fat that burns calories for heat, but in a new study, researchers found that this biological response is hampered in obese people. Belly fat samples were analyzed to see if there was a difference …

In what may be a step toward a cure for type 1 diabetes, researchers say they’ve developed a large-scale method for turning human embryonic stem cells into fully functioning beta cells capable of producing insulin. They ultimately envision a credit card-sized package of beta cells that can be safely transplanted …

After two years, only 19 of original 32 CMS Pioneer ACO’s still participating. See this week’s Tool for Your Practice and Letter from the Editor.